Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

INmune Bio Inc. Common stock (INMB)

Biological Products, (no Disgnostic Substances)

https://www.inmunebio.com

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

225 NE MIZNER BLVD, SUITE 640
BOCA RATON, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/04/2019

Market Cap

139,960,480

Shares Outstanding

18,020,000

Weighted SO

18,000,000

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

TFFP --.--%

ANEB --.--%

ABCM --.--%

ANTX --.--%

CUE --.--%

ANIX --.--%

INAB --.--%

PYPD --.--%

AVTE --.--%

Beta

1.9400

Last Div

0.0000

Range

6.5-14.74

Chg

0.2050

Avg Vol

162337

Mkt Cap

139960480

Exch

NASDAQ

Country

US

Phone

858 964 3720

DCF Diff

5.9280

DCF

1.2920

Div Yield

0.0000

P/S

1646.5939

EV Multiple

-3.0253

P/FV

3.6839

Div Yield %

0.0000

P/E

-3.6193

PEG

-0.3492

Payout

0.0000

Current Ratio

2.3583

Quick Ratio

2.3583

Cash Ratio

2.0642

DSO

14655.8235

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

1.0000

Op Margin

-444.5765

Pretax Margin

-444.0235

Net Margin

-444.0235

Eff Tax Rate

0.3864

ROA

-0.7195

ROE

-1.0134

ROCE

-1.0103

NI/EBT

1.0000

EBT/EBIT

0.9988

EBIT/Rev

-444.5765

Debt Ratio

0.1035

D/E

0.1465

LT Debt/Cap

0.0086

Total Debt/Cap

0.1278

Int Coverage

334.4159

CF/Debt

-4.2399

Equity Multi

1.4146

Rec Turnover

0.0249

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.2342

Asset Turnover

0.0016

OCF/Share

-1.1927

FCF/Share

-1.1927

Cash/Share

1.6092

OCF/Sales

-270.9059

FCF/OCF

1.0000

CF Coverage

-4.2399

ST Coverage

-4.5071

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

3.6839

P/B

3.6839

P/S

1646.5939

P/E

-3.6193

P/FCF

-6.0781

P/OCF

-5.9321

P/CF

-5.9321

PEG

-0.3492

P/S

1646.5939

EV Multiple

-3.0253

P/FV

3.6839

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 30, 09:07 INmune Bio Inc. Presents Preclinical Data at SITC 2023 Showing INB03 is an Innate Immune Check Point Inhibitor that Downregulates SIRPα

Revenue Product Segmentation